Pembrolizumab as Second-Line Therapy for Advanced Urothelial Carcinoma. (Q41979947)
Jump to navigation
Jump to search
scientific article published on 17 February 2017
Language | Label | Description | Also known as |
---|---|---|---|
English | Pembrolizumab as Second-Line Therapy for Advanced Urothelial Carcinoma. |
scientific article published on 17 February 2017 |
Statements
Pembrolizumab as Second-Line Therapy for Advanced Urothelial Carcinoma (English)
Joaquim Bellmunt
Ronald de Wit
David J Vaughn
Yves Fradet
Jae-Lyun Lee
Lawrence Fong
Nicholas J Vogelzang
Miguel A Climent
Daniel P Petrylak
Winald Gerritsen
David I Quinn
Stéphane Culine
Cora N Sternberg
Yabing Mai
Christian H Poehlein
Rodolfo F Perini
Dean F Bajorin
KEYNOTE-045 Investigators
17 February 2017
1 reference